Project ACCEPT: Engaging Newly Diagnosed HIV+ Youth in Care

The proposed study is a two-group randomized repeated measures design that will examine the efficacy of Project ACCEPT (Adolescents Coping, Connecting, Empowering and Protecting Together) to improve engagement in care among youth newly diagnosed with HIV at five AMTU sites across the United States. Youth will be randomized into one of two study arms; Project ACCEPT, the intervention, or HEALTH, the health education attention-controlled comparison condition. Both arms consist of two individual sessions followed by six group sessions and a final individual session which is expected to take approximately nine weeks after which youth will have four follow-up visits at the following time points:

• post intervention (immediately after the last session);
• 3 months post the last session;
• 6 months post the last session; and
• 12 months post the last session. The trial will be repeated in up to three waves.

Study Overview

• Status: Completed
• Conditions: HIV Positive Youth That Are Newly Engaged in Care
• Intervention / Treatment: Behavioral: Project ACCEPT; Behavioral: HEALTH

• Study Type: Interventional
• Enrollment (Actual): 167
• Phase: Not Applicable

Contacts and Locations

Study Locations

• United States
  • Florida
    • Miami, Florida, United States, 33101
      • University of Miami School of Medicine
  • Illinois
    • Chicago, Illinois, United States, 60612
      • Stroger Hospital and the CORE Center
  • Michigan
    • Detroit, Michigan, United States, 48201
      • Wayne State University
  • Tennessee
    • Memphis, Tennessee, United States, 38105
      • St. Jude Childrens Research Hospital

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 16 years to 24 years (Child, Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• HIV-infected and aware of his/her status as documented by medical record review or verbal verification by provider (i.e., medical or mental health care provider, case manager, social worker, etc.);
• Received HIV diagnosis within the past 12 months (+ 3 months) at the time of consent/assent as documented by medical record review or verbal verification with referring professional (i.e., medical or mental health care provider, case manager, social worker, etc.);
• Between the ages of 16-24 (inclusive) at the time of informed consent/assent;
• Receives services at one of the selected AMTUs or one of their community partners;
• Willing to participate in both the individual and group sessions;
• Ability to speak and understand spoken English;
• Able to understand and willing to provide signed informed consent/assent in English or Spanish; and
• Willingness to provide signed informed consent or assent with parental/legal guardian permission as applicable.

Exclusion Criteria:

• Participated in a previous wave, if enrolling into Wave 2 or 3;
• Intoxicated or under the influence of alcohol or other substances at the time of consent/assent;
• Visibly distraught and/or visibly emotionally unstable (i.e., exhibiting suicidal, homicidal, or violent behavior) in the opinion of the site personnel would interfere with the ability to give true informed consent; and
• Any concurrent participation in other behavioral studies. Permission from the protocol team may be provided for uncertain cases.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Supportive Care
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Project ACCEPT; Participants randomized to the intervention (Project ACCEPT) arm.	Behavioral: Project ACCEPT; The intervention, Project ACCEPT, combines weekly individual and group sessions that address a range of issues that impact engagement in care for youth living with HIV, including stigma, disclosure, health relationships, substance use, and future life plans.; Other Names: Adolescents Coping, Connecting, Empowering and Protecting Together
Active Comparator: HEALTH; Participants randomized to the comparison (HEALTH) arm.	Behavioral: HEALTH; The comparison condition, HEALTH, matches Project ACCEPT in number of sessions and duration. The weekly sessions will cover information on alcohol, drugs, HIV and other sexually transmitted diseases (STDs) to meet the ethical responsibility to provide risk reduction information to youth assigned.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Examine the efficacy of Project ACCEPT compared with an attention-controlled health education comparison intervention	Conduct a randomized controlled trial to examine the efficacy of Project ACCEPT compared with an attention-controlled health education comparison intervention (HEALTH). The goals of the intervention are to improve engagement in care, decrease psychosocial barriers to care, and decrease sexual risk for youth newly diagnosed with HIV.	3 years

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Explore the relationship between HIV biomarkers and participant's level of engagement in care	Explore the relationship between HIV biomarkers (i.e., CD4 and viral load) and participant's level of engagement in care.	3 years

Collaborators and Investigators

• Sponsor: University of North Carolina, Chapel Hill
• Collaborators: National Institute on Drug Abuse (NIDA); National Institute of Mental Health (NIMH)
• Investigators: Study Chair: Sybil Hosek, PhD, Adolescent Trials Network; Study Chair: Gary Harper, PhD, Adolescent Trials Network

Publications and helpful links

Helpful Links

• ATN Website

Study record dates

Study Major Dates

• Study Start: January 1, 2013
• Primary Completion (Actual): June 1, 2015
• Study Completion (Actual): June 1, 2015

Study Registration Dates

• First Submitted: December 14, 2012
• First Submitted That Met QC Criteria: December 14, 2012
• First Posted (Estimate): December 18, 2012

Study Record Updates

• Last Update Posted (Actual): February 28, 2017
• Last Update Submitted That Met QC Criteria: February 27, 2017
• Last Verified: October 1, 2016

More Information

Terms related to this study

• Additional Relevant MeSH Terms: RNA Virus Infections; Virus Diseases; Infections; Blood-Borne Infections; Communicable Diseases; Sexually Transmitted Diseases, Viral; Sexually Transmitted Diseases; Lentivirus Infections; Retroviridae Infections; Immunologic Deficiency Syndromes; Immune System Diseases; HIV Infections; HIV Seropositivity
• Other Study ID Numbers: ATN 108